Skip to content
Parker Institute for Cancer Immunotherapy
Search Close

Ari Bitton, MSc

Senior Clinical Program Manager

Clinical Development


Ari Bitton, MSc, is the senior clinical trial manager for PICI0033 (PORTER) platform clinical trial, evaluating biomarkers and immunotherapy combinations for the treatment of patients with metastatic castration-resistant prostate cancer. Bitton’s role focuses on advancing the study from planning through execution and touches all logistical components in between.

Prior to joining PICI, Bitton spent close to 10 years in clinical development working in a number of therapeutic areas, including oncology, neurology and rare/orphan disease.

Bitton’s background includes a masters and bachelors of science from McGill University and San Francisco State University, experience as a paramedic and patient care provider as well as working on clinical trials and international health partnership programs spanning the U.S., Tanzania and Uganda.